Safety of the Immediate Reconstitution of Poly‐l‐Lactic Acid for Facial and Body Treatment—A Multicenter Retrospective Study

疤痕 医学 不利影响 小瓶 回顾性队列研究 外科 生理盐水 病历 面部修复 乳酸 套管 内科学 化学 生物 细菌 遗传学 物理化学
作者
Franziska Wenz,Julia Real,Franziska Wenz,Luiz Eduardo Toledo Avelar
出处
期刊:Journal of Cosmetic Dermatology [Wiley]
标识
DOI:10.1111/jocd.16560
摘要

ABSTRACT Background Poly‐ l ‐lactic acid (PLLA‐SCA; Sculptra) was approved in 1999 in Europe and 2004 in United States as a collagen biostimulator. It is a freeze‐dried preparation containing 150 mg PLLA‐SCA per vial and, since approval, has been recommended to be reconstituted 72 h before treatment, which can hinder its use in clinical practice. In 2021, the manufacturer authorized the reconstitution of PLLA‐SCA immediately before use. Objective To evaluate adverse events in patients treated with immediately reconstituted PLLA‐SCA on the face, body, and scars. Method This was a retrospective analysis of medical records of patients treated with immediately reconstituted PLLA‐SCA for aesthetic purposes from January 1, 2021, to December 31, 2021, at two medical centers. Results A total of 274 treatment sessions were conducted on 167 patients (ranging from 1 to 5 sessions per patient). Of these, 228 sessions (151 patients) targeted the face, 39 sessions (22 patients) addressed the body, and 7 sessions (5 patients) focused on scars. The mean final concentration of PLLA‐SCA was 15.30 mg/mL for the face, 8.35 mg/mL for the body, and 10.53 mg/mL for scars. The majority of injections were administered with a blunt cannula (face: 87.3%, body: 100%, scars: 57%), and in 6 out of 7 scar treatments, PLLA‐SCA was additionally applied topically after fractional treatment. One patient developed a PLLA‐SCA nodule 30 days after facial treatment, which resolved after two saline injections. The most common adverse events were bruising (face: 6.57%, body: 7.69%) and mild pain (face: 3.07%). No events required further intervention. Conclusion This study reports an adverse event profile with immediately reconstituted PLLA‐SCA, used on the face, body, and scars, similar to that reported with PLLA‐SCA reconstituted 72 h prior to use. Trial Registration This was a retrospective study of medical records at two medical centers, and trial registration was not required.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
march发布了新的文献求助10
1秒前
keyan完成签到 ,获得积分10
2秒前
伶俐云朵完成签到,获得积分10
2秒前
jyxm完成签到,获得积分10
3秒前
呆瓜不呆的应助被温暖砖头采纳,获得10
3秒前
可乐爱喝奶茶完成签到,获得积分10
3秒前
4秒前
5秒前
成就念芹发布了新的文献求助10
5秒前
请输入昵称完成签到 ,获得积分10
6秒前
lili发布了新的文献求助10
7秒前
8秒前
无情醉易发布了新的文献求助10
8秒前
9秒前
9秒前
曦_完成签到,获得积分10
9秒前
Jasper的应助被123采纳,获得10
9秒前
炙热代丝完成签到,获得积分10
10秒前
栗心完成签到,获得积分10
10秒前
si发布了新的文献求助10
12秒前
fanfan完成签到 ,获得积分10
12秒前
12秒前
13秒前
Freedom完成签到 ,获得积分10
13秒前
Jasper的应助被项空月采纳,获得10
13秒前
豆芽菜发布了新的文献求助10
13秒前
科研小白发布了新的文献求助10
14秒前
14秒前
田様的应助被shiyue采纳,获得10
14秒前
丘比特的应助被jjdeng采纳,获得10
15秒前
领导范儿的应助被皮不可采纳,获得10
15秒前
bkagyin的应助被ayzzdbr采纳,获得10
15秒前
FashionBoy的应助被KTLJ采纳,获得10
15秒前
温岚完成签到,获得积分10
15秒前
沈樾完成签到,获得积分10
16秒前
17秒前
天真烨磊完成签到 ,获得积分10
17秒前
17秒前
18秒前
施不评发布了新的文献求助10
18秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
John McDowells Bildungstheorie 800
八旗制度の研究 600
plantTFDB 508
Resource Recovery Handbook 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8175534
求助须知:如何正确求助?哪些是违规求助? 9567220
关于积分的说明 21791292
捐赠科研通 7770111
什么是DOI,文献DOI怎么找? 3431868
关于科研通互助平台的介绍 2556244
邀请新用户注册赠送积分活动 2477299